ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MCGN Microgen

367.50
0.00 (0.00%)
25 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Microgen LSE:MCGN London Ordinary Share GB00BVVHWX30 ORD 6 3/7P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 367.50 365.00 370.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Microgen PLC AGM Trading update (0157D)

24/04/2017 7:00am

UK Regulatory


Microgen (LSE:MCGN)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Microgen Charts.

TIDMMCGN

RNS Number : 0157D

Microgen PLC

24 April 2017

microgen

www.microgen.com

24 April 2017

AGM Trading Update

Ivan Martin, Chairman of Microgen plc ("Group"), will provide the following trading update at the Annual General Meeting to be held at 9.00 a.m. this morning.

"The Board is pleased to confirm that each of the Group's two businesses have made a strong start to 2017.

The Aptitude Software business has built on the excellent progress it achieved in 2016 with a number of successes in both new and existing markets. Aptitude Software has successfully developed its presence in the US healthcare market with two material contracts secured since the start of the year. The opening of this important new market in 2017 complements the continued demand for the Aptitude Revenue Recognition Engine from telcos as they work towards the implementation of IFRS 15 and ASC 606, accounting standards which are effective for annual reporting periods beginning on or after 1 January 2018.

Microgen Financial Systems continues to focus on growing its Trust & Fund Administration business ("T&FA") through a combination of organic growth and add-on acquisitions. New business progress has continued in 2017 complemented by a number of customers acquired with the add-on acquisitions committing to convert to Microgen 5Series in line with the strategy of the business. In February 2017 the business announced the acquisition of Primacy Corporation, the fifth add-on acquisition within T&FA since December 2014. The integration of Primacy Corporation continues in line with expectations.

The Board remains confident that the progress at the start of 2017 will continue throughout the year."

Contacts

   Ivan Martin, Chairman                                                   020-7496-8100 

Philip Wood, Chief Financial Officer

   Darius Alexander, FTI Consulting                                    020-3727-1063 

This information is provided by RNS

The company news service from the London Stock Exchange

END

AGMIBMBTMBJTBPR

(END) Dow Jones Newswires

April 24, 2017 02:00 ET (06:00 GMT)

1 Year Microgen Chart

1 Year Microgen Chart

1 Month Microgen Chart

1 Month Microgen Chart

Your Recent History

Delayed Upgrade Clock